Atea Pharmaceuticals Inc. (AVIR)
NASDAQ: AVIR
· Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT
Atea Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 416K | 416K | 416K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 192.18M | 224.99M | 285.38M | 351.37M | 207.82M | 175.01M | 114.62M |
Cost of Revenue | 312K | 312K | 312K | 416K | 416K | 416K | 416K | 416K | 15.46M | 15.4M | 15.32M | 15.22M | 43.09M | 82.85M | 109.4M | 123.24M | 93.82M | 61.77M |
Gross Profit | -104K | -104K | -104K | -416K | -416K | -416K | -416K | -416K | -15.46M | -15.4M | -15.32M | 176.96M | 181.9M | 202.53M | 241.97M | 84.58M | 81.19M | 52.84M |
Operating Income | -156.61M | -162.19M | -192.95M | -200.5M | -204.08M | -192.4M | -164.16M | -157.49M | -132.98M | -130.04M | -130.65M | 30.43M | 24.56M | 65.55M | 138.38M | 37.84M | 42.36M | 23.67M |
Interest Income | 21.35M | 23.59M | 25.49M | 27.54M | 29.13M | 29.79M | 29.22M | 27.06M | 23.57M | 17.35M | 11.15M | 5.61M | 1.28M | 254K | 214K | 172K | 126K | 84K |
Pretax Income | -135.27M | -138.59M | -167.46M | -172.96M | -174.95M | -162.61M | -134.94M | -130.43M | -109.41M | -112.69M | -119.5M | 36.04M | 25.85M | 65.8M | 138.59M | 38.01M | 42.49M | 23.75M |
Net Income | -136.13M | -139.49M | -168.38M | -174.01M | -176M | -163.66M | -135.96M | -131.22M | -106.15M | -109.3M | -115.81M | 35.75M | 15.62M | 48.5M | 121.19M | 24.71M | 35.29M | 23.75M |
Selling & General & Admin | 42.92M | 45.97M | 48.64M | 46.71M | 48.27M | 49.33M | 49.81M | 50.75M | 49.52M | 48.79M | 48.71M | 49.54M | 50.11M | 49.57M | 45.79M | 46.74M | 38.83M | 29.18M |
Research & Development | 113.69M | 116.11M | 144.1M | 153.47M | 155.5M | 142.86M | 114.24M | 106.74M | 83.46M | 81.26M | 81.94M | 112.21M | 150.32M | 170.27M | 167.2M | 123.24M | 93.82M | 61.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 156.61M | 162.08M | 192.74M | 200.19M | 203.77M | 192.19M | 164.06M | 157.49M | 132.98M | 130.04M | 130.65M | 161.75M | 200.43M | 219.84M | 212.99M | 169.98M | 132.65M | 90.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -104K | -208K | -312K | -312K | -208K | -104K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 156.61M | 162.19M | 192.95M | 200.5M | 204.08M | 192.4M | 164.16M | 157.49M | 132.98M | 130.04M | 130.65M | 161.75M | 200.43M | 219.84M | 212.99M | 169.98M | 132.65M | 90.95M |
Income Tax Expense | 455K | 491K | 925K | 1.05M | 1.04M | 1.05M | 1.02M | 792K | -3.26M | -3.39M | -3.69M | 289K | 10.22M | 17.3M | 17.4M | 13.3M | 7.2M | n/a |
Shares Outstanding (Basic) | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 83.1M | 82.82M | 82.74M | 82.58M |
Shares Outstanding (Diluted) | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 87.09M | 82.82M | 88.09M | 89.1M |
EPS (Basic) | -1.61 | -1.65 | -2 | -2.07 | -2.1 | -1.96 | -1.64 | -1.58 | -1.28 | -1.32 | -1.39 | 0.43 | 0.19 | 0.59 | 1.46 | 0.30 | 0.42 | 0.19 |
EPS (Diluted) | -1.61 | -1.65 | -2 | -2.07 | -2.1 | -1.96 | -1.64 | -1.58 | -1.28 | -1.32 | -1.39 | 0.36 | 0.12 | 0.52 | 1.36 | 0.25 | 0.37 | 0.14 |
EBITDA | -150.8M | -156.37M | -187.03M | -192.53M | -196.11M | -184.43M | -156.2M | -151.69M | -127.19M | -124.25M | -124.95M | 30.44M | 24.59M | 65.58M | 138.41M | 37.87M | 42.39M | 23.69M |
EBIT | -141.54M | -151.5M | -187.24M | -192.74M | -196.32M | -184.64M | -156.4M | -157.49M | -128.6M | -125.66M | -126.27M | 34.81M | 24.56M | 65.6M | 138.49M | 37.96M | 42.48M | 23.74M |
Depreciation & Amortization | 312K | 416K | 416K | 416K | 416K | 416K | 416K | 416K | 418K | 357K | 276K | 179K | 80K | 45K | 29K | 28K | 26K | 22K |